BREAKING: Johnson & Johnson finally unveils its new robot-assisted surgery system

Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market.

The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform has a zero-footprint design to enable patient access, increase space in the operating room and improve workflow.

J&J’s unveiling included a name for the new platform: Ottava.

In Italian, “Ottava” means to play music an octave higher, according to J&J robotics chief development officer Dr. Frederic Moll, an Intuitive Surgical co-founder who joined J&J through its acquisition of his Auris Health in 2019.

“That (an octave higher) is what we mean to enable in medical intervention,” Moll said during a medical device update presentation today.

Robot-assisted surgery is currently a hot area in medtech — with J&J, Medtronic and others seeking to take on Intuitive Surgical (NSDQ:ISRG), which dominates the space with its da Vinci robots.

J&J believes its developing platform offers more than any other available system in terms of flexibility.

“Currently, there is no robotic system that provides robotic control and coordination across a full breadth of procedures,” Moll said. “It is my team’s ambition to enable our platform to improve outcomes across a broad range of disease states.”

Moll said J&J is in the “exciting stage of development” where the platform is “coming to life.”

The company is planning on beginning verification and validation processes for Ottava in 2021, followed by enrollment in clinical trials for the device in 2022.

J&J’s digital ecosystem — designed to connect its surgical and robotic platforms  — is set to power Ottava, while the company has eyes on combining it with the FDA-cleared Monarch robotic surgical platform acquired from Auris Health to access and treat challenging anatomy in a minimally invasive way.

By Sean Whooley | MassDevice

Image Credit: Johnson & Johnson


About Peter Coffaro 504 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.